Episode 6 – Autoantibodies as biomarkers

Update: 2024-01-05

Description

“Changes in antibody concentrations should influence your therapeutic decision.” Professor Nils Erik Gilhus is joined by Professor Marc De Baets to discuss the importance of regularly measuring autoantibodies to support treatment decisions in people with MG.

Comments

In Channel

Episode 17 – The urgency of myasthenic crisis

2025-10-0822:04

Episode 16 - Life beyond MG

2025-03-2016:27

Episode 15 - The nature of myasthenia gravis

2025-03-2015:49

Episode 14 - New and improved assays for detecting antibodies

2024-09-2316:21

Episode 13 – EAN 2024 special

2024-07-2917:36

Episode 12 – Late-onset myasthenia gravis

2024-06-2818:01

Episode 11 – Steroids in myasthenia gravis

2024-05-1716:07

Episode 10 – Unmet needs in myasthenia gravis

2024-04-1915:43

Episode 9 – Pregnancy and myasthenia gravis

2024-03-2716:16

Episode 8 – Diagnostic delay in myasthenia gravis

2024-03-0718:10

Episode 7 – Physical exercise in myasthenia gravis

2024-01-2418:01

Episode 6 – Autoantibodies as biomarkers

2024-01-0514:56

Episode 5 – Myasthenia gravis: A global perspective

2023-11-1719:12

Episode 4 – Targeted therapies in myasthenia gravis

2023-10-2018:25

Episode 3 – Myasthenia gravis: A patient perspective

2023-09-1514:40

Episode 2 – EAN 2023: Highlights and key takeaways

2023-07-2722:22

Episode 1 – Myasthenia gravis 101: Disease burden, diagnosis, treatment landscape, and outcomes

2023-07-2719:23

00:00

1.0x

Episode 6 – Autoantibodies as biomarkers

#box-pro-ellipsis-176426363779476{-webkit-line-clamp:2;}Episode 6 – Autoantibodies as biomarkers

Episode 6 – Autoantibodies as biomarkers

medthority

Episode 6 – Autoantibodies as biomarkers